Centrillion Technologies

Centrillion Technologies is an innovative developer of next-generation DNA chip technology, leveraging proprietary chemistry and manufacturing to enable high-throughput, high-accuracy genomic analyses. Its core product lines include the VirusHunter™ assays for SARS-CoV-2 detection and variant tracking, whole-genome genotyping services, and a developing spatial transcriptomics platform. The company operates both as a technology provider and through its clinical lab, Molecular Vision Laboratories, positioning itself in the high-growth genomics and molecular diagnostics markets.

Next-generation DNA chip platform utilizing proprietary surface chemistry compatible with enzymatic reactions and advanced photolithography manufacturing for high-density, high-fidelity microarrays. Enables applications in sequencing, genotyping, pathogen detection, and spatial transcriptomics.

Centrillion competes in fragmented but crowded markets. In infectious disease Dx/sequencing, it faces giants like Thermo Fisher and Illumina, plus numerous specialty firms. In spatial genomics, it would challenge 10x Genomics and NanoString. Its differentiation hinges on its unique chip chemistry enabling simpler workflows and potentially superior resolution.